Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2011

Jul 18, 2011

30071_dirs_2011-07-18_37ba57f5-58d0-486d-8bed-a17a1f183ca4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2011-07-14

Reporting Person: Sandercock Brett (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-07-14 ResMed Common Stock M 50000 $21.025 Acquired 100111.86 Direct
2011-07-14 ResMed Common Stock S 50000 $32.50 Disposed 50111.86 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-07-14 ResMed Common Stock Options $21.025 M 50000 Disposed 2014-11-07 ResMed Common Stock (50000) Direct

Footnotes

F1: This transaction was done in accordance with a 10b5-1 trading plan.

F2: Represents first day options became exercisable.